Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2400
-0.0020 (-0.83%)
At close: Jun 25, 2026

Inhalation Sciences Sweden AB Company Description

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation drugs, as well as for inhalation toxicity studies in rodents; and intratracheal exposure module, an unique technology delivering aerosol directly to the lungs, bypassing the nose, and to spontaneously breathing rodents.

Inhalation Sciences Sweden AB (publ) was incorporated in 2004 and is headquartered in Huddinge, Sweden.

Inhalation Sciences Sweden AB (publ)
CountrySweden
Founded2004
IndustrySurgical and Medical Instruments and Apparatus
Employees5
CEOManoush Masarrat

Contact Details

Address:
Novum floor 6
Huddinge, 141 57
Sweden
Phone46 7 05 62 51 95
Websiteinhalation.se

Stock Details

Ticker SymbolISAB
ExchangeSpotlight Stock Market
Fiscal YearJanuary - December
Reporting CurrencySEK
SIC Code3841

Key Executives

NamePosition
Manoush MasarratChief Executive Officer